Personalizing blood sugar targets for better diabetes management
Towards optimizing diabetes management and diagnosis by personalizing HbA1c targets
This study is looking at how we can better manage diabetes by personalizing blood sugar targets, so people with diabetes can get treatment plans that fit their unique needs based on their blood sugar levels.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Cincinnati NIH-funded |
| Lab location | 1 site (Cincinnati, United States) |
| Project ID | NIH-10817099 on NIH RePORTER |
What this research studies
This research focuses on improving diabetes management by personalizing the targets for Hemoglobin A1c (HbA1c), a key indicator of blood sugar levels. It investigates the discrepancies between HbA1c and average glucose levels, particularly how variations in red blood cell lifespan may affect these measurements. By utilizing advanced techniques to measure red blood cell age, the study aims to clarify the relationship between HbA1c and glucose management indicators, potentially leading to more accurate diabetes care. Patients may benefit from tailored treatment plans based on their unique blood sugar profiles.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with diabetes who are currently monitored using HbA1c levels.
Not a fit: Patients without diabetes or those who do not undergo HbA1c testing may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate diabetes management strategies, reducing complications and improving patient outcomes.
How similar studies have performed: Other research has shown promise in using continuous glucose monitoring to improve diabetes management, but this specific approach to personalizing HbA1c targets is relatively novel.
Where this research is happening
Cincinnati, United States
- University of Cincinnati — Cincinnati, United States (Active)
Researchers
- Principal investigator: Cohen, Robert Maynard — University of Cincinnati
- Study coordinator: Cohen, Robert Maynard
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.